http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2020002165-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
filingDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e
publicationDate 2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2020002165-A1
titleOfInvention Use of tradipitant to treat motion sickness.
abstract Described herein is a method of treating or preventing motion sickness or at least one symptom thereof, which comprises treatment with the NK-1 receptor antagonist, tradipitant.
priorityDate 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9916461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419676935

Total number of triples: 16.